1034617-66-7
1034617-66-7
Chemical Structure
PLK1-IN-17
- CAS No.: 1034617-66-7
- Formula:C22H23F3N8O2
- Molecular Weight:488.47
InChIKey: TUWAYASUNDRSML-UHFFFAOYSA-N
SMILES: O=C(C1=NN(C)C2=C1CCC3=C2N=C(NC4=CC(N5CCNCC5)=CC=C4OC(F)(F)F)N=C3)N
Biological Activity: PLK1-IN-17 is a potent PLK1 inhibitor with an IC50 of 2 nM. PLK1-IN-17 shows high selectivity for PLK2 and CDK2/A, moderate selectivity for PLK3, only weak activity against CK2, FLT3 and NEK6, and no activity against PDGFR, ALK and another 37 kinases. PLK1-IN-17 inhibits the proliferation of ovarian cancer cells and can be used in ovarian cancer-related research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PLK1-IN-17 | PLK1-IN-17 is a potent PLK1 inhibitor with an IC50 of 2 nM. PLK1-IN-17 shows high selectivity for PLK2 and CDK2/A, moderate selectivity for PLK3, only weak activity against CK2, FLT3 and NEK6, and no activity against PDGFR, ALK and another 37 kinases. PLK1-IN-17 inhibits the proliferation of ovarian cancer cells and can be used in ovarian cancer-related research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
